More specifically, a novel animal model of breast cancer metastasizing to bone has been investigated which consisted of injecting human CD44+/CD24−/low BCSCs subpopulation from MDA-MB-231 cells in mice previously implanted with human bone in the right or left dorsal flanks [253]. The gene discussed is CD44; the disease is breast cancer.